Literature DB >> 10071057

Infratentorial atrophy on magnetic resonance imaging and disability in multiple sclerosis.

S G Edwards1, Q Y Gong, C Liu, M E Zvartau, T Jaspan, N Roberts, L D Blumhardt.   

Abstract

Loss of tissue volume in the central nervous system may provide an index of fixed neurological dysfunction in multiple sclerosis. Recent magnetic resonance studies have shown a modest relationship between clinical disability rating scores and transverse sectional area of the cervical spinal cord. To explore further the relationship between atrophy and disability in multiple sclerosis, we estimated the volumes of infratentorial structures from MRIs in a cross-sectional study of 41 patients, 21 with relapsing-remitting multiple sclerosis and 20 with secondary progressive multiple sclerosis. We used the Cavalieri method of modern design stereology with point counting to estimate the volume of brainstem, cerebellum and upper cervical spinal cord from three-dimensional MRIs acquired with an MPRAGE (Magnetization-prepared Rapid Acquisition Gradient Echo) sequence. The volume of the upper (C1-C3) cervical spinal cord was significantly correlated with a composite spinal cord score derived from the appropriate Functional Scale scores of the Expanded Disability Status Scale (r = -0.50, P < 0.01). The cerebellar (r = 0.49, P < 0.01) and brainstem (r = 0.34, P < 0.05) volumes correlated with the Scripp's Neurological Disability Rating Scale scores. The upper cervical cord volumes (r = -0.39, P < 0.01), but not the brainstem or cerebellar volumes, were significantly associated with disease duration. MRI-estimated structural volumes may provide a simple index of axonal and/or myelin loss, the presumed pathological substrates of irreversible impairment and disability in multiple sclerosis.

Entities:  

Mesh:

Year:  1999        PMID: 10071057     DOI: 10.1093/brain/122.2.291

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  21 in total

1.  Sensitivity and reproducibility of a new fast 3D segmentation technique for clinical MR-based brain volumetry in multiple sclerosis.

Authors:  Carsten Lukas; Horst K Hahn; Barbara Bellenberg; Jan Rexilius; Gebhard Schmid; Sebastian K Schimrigk; Horst Przuntek; Odo Köster; Heinz-Otto Peitgen
Journal:  Neuroradiology       Date:  2004-11-05       Impact factor: 2.804

2.  Sulcal variability, stereological measurement and asymmetry of Broca's area on MR images.

Authors:  Simon Sean Keller; John Robin Highley; Marta Garcia-Finana; Vanessa Sluming; Roozbeh Rezaie; Neil Roberts
Journal:  J Anat       Date:  2007-08-29       Impact factor: 2.610

3.  Cortical atrophy in experimental autoimmune encephalomyelitis: in vivo imaging.

Authors:  Allan MacKenzie-Graham; Gilda A Rinek; Andrea Avedisian; Stefan M Gold; Andrew J Frew; Cynthia Aguilar; David R Lin; Elizabeth Umeda; Rhonda R Voskuhl; Jeffry R Alger
Journal:  Neuroimage       Date:  2011-12-13       Impact factor: 6.556

4.  1H-magnetic resonance spectroscopy in diffuse and focal cervical cord lesions in multiple sclerosis.

Authors:  Barbara Bellenberg; Martin Busch; Nadine Trampe; Ralf Gold; Andrew Chan; Carsten Lukas
Journal:  Eur Radiol       Date:  2013-07-25       Impact factor: 5.315

Review 5.  Brain and spinal cord atrophy in multiple sclerosis: role as a surrogate measure of disease progression.

Authors:  J H Simon
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

6.  Infratentorial lesion volume correlates with sensory functional system in multiple sclerosis patients: a 3.0-Tesla MRI study.

Authors:  C C Quattrocchi; A Cherubini; G Luccichenti; M G Grasso; U Nocentini; B Beomonte Zobel; U Sabatini
Journal:  Radiol Med       Date:  2009-12-16       Impact factor: 3.469

Review 7.  Interventions for the prevention of brain atrophy in multiple sclerosis : current status.

Authors:  Marco Rovaris; Massimo Filippi
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

8.  Bringing CLARITY to gray matter atrophy.

Authors:  Rory D Spence; Florian Kurth; Noriko Itoh; Chandler R L Mongerson; Shannon H Wailes; Mavis S Peng; Allan J MacKenzie-Graham
Journal:  Neuroimage       Date:  2014-07-16       Impact factor: 6.556

9.  Spinal cord atrophy and disability in multiple sclerosis over four years: application of a reproducible automated technique in monitoring disease progression in a cohort of the interferon beta-1a (Rebif) treatment trial.

Authors:  X Lin; C R Tench; B Turner; L D Blumhardt; C S Constantinescu
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-08       Impact factor: 10.154

10.  Corticospinal tract abnormalities are associated with weakness in multiple sclerosis.

Authors:  D S Reich; K M Zackowski; E M Gordon-Lipkin; S A Smith; B A Chodkowski; G R Cutter; P A Calabresi
Journal:  AJNR Am J Neuroradiol       Date:  2007-11-01       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.